High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy

References

• N.A.M.S. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 Position Statement of the North American Menopause Society. Menopause 2007;14:357–369.
   Google Scholar
• Rioux JE, Devlin C, Gelfand MM, Steinberg WM, Hepburn DS. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 2000;7:156–161.
   PubMed Web of Science ®Google Scholar
• Kendall A, Dowsett M, Folkerd E, Smith I. Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors. Ann Oncol 2006;17:584–587.
   PubMed Web of Science ®Google Scholar
• Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, Martel C, Labrie C, Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women. Menopause 2009;16:30–36.
   PubMed Web of Science ®Google Scholar
• Labrie F, Luu-The V, Bélanger A, Lin S-X, Simard J, Labrie C. Is DHEA a hormone? Starling Review. J Endocrinol 2005;187:169–196.
   PubMed Web of Science ®Google Scholar
• Labrie F. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy. Nat Clin Pract Endocrinol Metab 2007;3:584–593.
   PubMedGoogle Scholar
• Labrie F, DHEA after Menopause - Sole source of sex steroids and potential sex steroid deficiency treatment. Menopause Management 2010;19:14–24.
   Google Scholar
• Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, et al Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 2006;99:182–188.
   PubMed Web of Science ®Google Scholar
• Berger L, El-Alfy M, Martel C, Labrie F. Effects of dehydroepiandrosterone, premarin and acolbifene on histomorphology and sex steroid receptors in the rat vagina. J Steroid Biochem Mol Biol 2005;96:201–215.
   PubMed Web of Science ®Google Scholar
• Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, et al Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy. Menopause, 2009;16:907–922.
   Google Scholar
• Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard D, Baron M, Ayotte N, Moreau M, et al Effect on intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause, 2009;16:923–931.
   Google Scholar
• Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, et al Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration. Menopause 2009;16:897–906.
   Google Scholar
• Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, et al Corrigendum to: Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. J Steroid Biochem Mol Biol 2008;112:169.
   Web of Science ®Google Scholar
• Labrie F, Cusan L, Gomez JL, Côté I, Bérubé R, Bélanger P, et al Effect of intravaginal DHEA on serum DHEA and eleven of its metabolites in postmenopausal women. J Steroid Biochem Mol Biol 2008;111:178–194.
   PubMed Web of Science ®Google Scholar
• Meisels A. The maturation value. Acta Cytol 1967;11:249.
   PubMed Web of Science ®Google Scholar
• Wied GL. Industrial developments in automated cytology as submitted by their developers. Anal Quant Cytol Histol 1993;15:358–370.
   PubMed Web of Science ®Google Scholar
• Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997;82:3498–3505.
   PubMed Web of Science ®Google Scholar
• Calvo E, Luu-The V, Morissette J, Martel C, Labrie C, Bernard B, et al Pangenomic changes induced by DHEA in the skin of postmenopausal women. J Steroid Biochem Mol Biol 2008;112:186–193.
   PubMedGoogle Scholar
• Labrie F, Cusan L, Gomez JL, Martel C, Berube R, Belanger P, Chaussade V, Deloche C, Leclaire J. Changes in serum DHEA and eleven of its metabolites during 12-month percutaneous administration of DHEA. J Steroid Biochem Mol Biol 2008;110:1–9.
   PubMed Web of Science ®Google Scholar
• Suh-Burgmann E, Sivret J, Duska LR, Del Carmen M, Seiden MV. Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia – a pilot study. Gynecol Obstet Invest 2003;55:25–31.
   PubMedGoogle Scholar